Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

Market Cap	11.57B
Revenue (ttm)	11.01B
Net Income (ttm)	-145.64M
Shares Out	556.89M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	21.19
Dividend	0.30 (1.45%)
Ex-Dividend Date	Jun 7, 2024

Volume	6,467,374
Average Volume	10,700,654
Open	20.68
Previous Close	20.77
Day's Range	20.63 - 20.96
52-Week Range	18.70 - 38.63
Beta	0.68
RSI	44.47
Earnings Date	Aug 28, 2025

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, develops, produces, and sells traditional Chinese and modern medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Commercial; Chinese Herbal Medicine Resources; and Service Industry and Others segments. The company offers digestive system and metabolic, respiratory system, cardiovascular and cerebrovascular, anti-infective, nervous system, and anti-tumor and immunomodulatory drugs; and health products. It also engages ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 12,589
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600129

Financial Performance

In 2024, SHA:600129's revenue was 12.39 billion, a decrease of -20.72% compared to the previous year's 15.62 billion. Earnings were 26.65 million, a decrease of -96.76%.